Viracept Den europeiske union - norsk - EMA (European Medicines Agency)

viracept

roche registration ltd. - nelfinavir - hiv-infeksjoner - antivirale midler til systemisk bruk - viracept er indisert ved antiretroviral kombinationsbehandling av hiv-1-infiserte voksne, ungdom og barn på tre år og eldre. i protease-inhibitor (pi)-erfarne pasienter, valg av nelfinavir bør være basert på individuelle viral motstand testing og behandling historie.

Xtandi Den europeiske union - norsk - EMA (European Medicines Agency)

xtandi

astellas pharma europe b.v. - enzalutamide - prostata neoplasmer - endokrin terapi - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

Maviret Den europeiske union - norsk - EMA (European Medicines Agency)

maviret

abbvie deutschland gmbh co. kg - glecaprevir, pibrentasvir - hepatitt c, kronisk - antivirale midler til systemisk bruk - maviret is indicated for the treatment of chronic hepatitis c virus (hcv) infection in adults and children aged 3 years and older. maviret coated granules is indicated for the treatment of chronic hepatitis c virus (hcv) infection in children 3 years and older.

Almina 28 100 mikrog / 20 mikrog Norge - norsk - Statens legemiddelverk

almina 28 100 mikrog / 20 mikrog

campuspharma ab - levonorgestrel / etinyløstradiol - tablett, filmdrasjert - 100 mikrog / 20 mikrog

Certican 0.25 mg Norge - norsk - Statens legemiddelverk

certican 0.25 mg

novartis norge (2) - everolimus - dispergerbar tablett - 0.25 mg

Certican 0.1 mg Norge - norsk - Statens legemiddelverk

certican 0.1 mg

novartis norge (2) - everolimus - dispergerbar tablett - 0.1 mg

Certican 0.25 mg Norge - norsk - Statens legemiddelverk

certican 0.25 mg

novartis norge (2) - everolimus - tablett - 0.25 mg

Certican 0.5 mg Norge - norsk - Statens legemiddelverk

certican 0.5 mg

novartis norge (2) - everolimus - tablett - 0.5 mg

Certican 0.75 mg Norge - norsk - Statens legemiddelverk

certican 0.75 mg

novartis norge (2) - everolimus - tablett - 0.75 mg

Certican 1 mg Norge - norsk - Statens legemiddelverk

certican 1 mg

novartis norge (2) - everolimus - tablett - 1 mg